A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT03598790 · COMPLETED
Trial details
- NCT number
- NCT03598790
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2023-11-14
- Enrollment
- 1353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.